Skip to content
MedsAcross

Molecule

Tipranavir

Presentations
0
Brands
0
Manufacturers
0
Available from stock
0

Tipranavir is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

ATC classification
J05AE09 Tipranavir · Direct acting antiviral, subgroup J05AE
US FDA first approval
22 June 2005
EU status
Authorised
Orphan designation
No
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Identifiers
UNII ZZT404XD09RxCUI 190548CAS 174484-41-4DrugBank DB00932Q423404

All presentations

No presentations of Tipranavir are listed yet. Ask us to source it

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 22 June 2005Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026

Conditions

Conditions linked to Tipranavir in public data. This is not a list of approved uses, see the clinical information.

Questions and answers

Is Tipranavir available for export from India?

No presentation of Tipranavir is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.

Is Tipranavir approved by the US FDA?

Yes. The US FDA first approved Tipranavir on 22 June 2005, according to Drugs@FDA.

Is Tipranavir authorised in the European Union?

Yes. Tipranavir has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.

Does Tipranavir need cold chain shipping?

No listed presentation of Tipranavir is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Tipranavir in?

Tipranavir is classified under ATC code J05AE09 (Tipranavir).

References

  1. Aptivus: European public assessment report (EPAR). European Medicines Agency. Retrieved 23 April 2026

Request Tipranavir for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.